1Jope RS, Yuskaitis CJ, Beurel E Glycogen synthase kinase-3 (GSK3): int'lanmation, diseases, and therapeutics[J]. Neurochem Res, 2007, 32(4/5): 577-595.
2Ruel I., Bourouis M, Heitzler P, et al. Droso-phila shaggy kinase and rat glycogen synthase kinas-3 have conserved activities and act downstream of Notch[J]. Nature, 1993, 362(6420): 557-560.
3Ruel I., Bourouis M, Heitzler P, et al. Droso-phila shaggy kinase and rat glycogen synthase kinas-3 have conserved activities and act downstream of Notch[J]. Nature, 1993, 362(6420):557-560.
4Luo J. Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy[J]. Cancer Lett, 2009, 273(2) : 194-200.
5Ma C, Wang J, Gao Y, et al. The role of glycogen synthase kinast2 3β in the transformation of epidermal cells[J]. Cancer Res, 2007, 67 (16): 7756-7764.
8Qu L, Huang S, Baltzl.s D, et aL Ei,doptasmic reticulum stress in duces p53 cytoplasmic localization and prevents p53-dcpcndent apopm sis by a pathway involving glycogen synthase kinase3beta[J]. Genes Dev, 2004, 18(3): 261-277.
9Ali A, Hoeflich KP, Woodgett JR. C-Iycogen synthase kinase3: properties, functions, and regulation[J].Chem Rev, 2001, 101(8): 2527-2540.
2Jemal A, Siegel R, Xu J, et al. Cancer statistics 2010 [ J ]. CA Cancer J Clin,2010,60(5) :277.
3Pan J,Zhang Q,Wang Y,et al. 26S proteasome activity is down-regulated in lung cancer stem-like cells propagated in vitro[ J]. PLoS One,2010,5(10) :e13298.
4Garcia Campelo MR, Alonso Curbera G, Aparicio Gallego G,et al. Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway[ J]. Clin Transl Oncol,2011,13(2) :77.
5Sananda Y,Yoshida K, Ohara M ,et al. Histopathologic eval- uation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric: epithelial transcrip- tion factor SOX2:comparison of expression patterns between invasive components and cancerous or nonneoplastic intra- ductal components [ J ]. Pancreas, 2006,32 ( 2 ) : 164.
6Sholl LM, Long KB, Hornick JL. SOX2 expression in pul- monary non-small cell and neuroendocrine carcinomas[ J]. Appl Immunohistochem Mol Morphol,2010,18 ( 1 ) : 55.
7Ying Y, Tao Q. Epigenetic disruption of the WNT/beta- catenin signaling pathway in human cancers [ J ]. Epigenet- ics ,2009,4(5 ) :307.
8Kormish JD,Sinner D,Zorn AM. Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease[ J]. Dev Dyn,2010,239 ( 1 ) :56.
9Mishra R. Glycogen synthase kinase 3 beta: can it be a tar- get for oral cancer[J]. Mol Cancer, 2010, 9:144.
10Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle [J]. Cell, 2002, 109(Suppl):S81-$96.
